Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians

Modou Jobarteh, Marine Malfroy, Ingrid Peterson, Adam Jeng, Ramu Sarge-Njie, Abraham Alabi, Kevin Peterson, Matt Cotten, Andrew Hall, Sarah Rowland-Jones, Hilton Whittle, Richard Tedder, Assan Jaye, Maimuna Mendy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)


Background. The prevalence of HIV/hepatitis co-infection in sub-Saharan Africa is not well documented, while both HIV and HBV are endemic in this area. Objective. The aim of this study is to determine the seroprevalence of HBV and HCV virus in HIV-infected subjects in the Gambia. Methods. Plasma samples from HIV infected patients (190 individuals with clinically defined AIDS and 382 individuals without AIDS) were tested retrospectively for the presence of HBV sero-markers and for serum HBV DNA, screened for HCV infection by testing for anti-HCV antibody and HCV RNA. Results. HBsAg prevalence in HIV-positive individuals is 12.2%. HIV/HBV co-infected individuals with CD4 count of <200 cells uL-1 have a higher HBV DNA viral load than patients with higher CD4 count (log 4.0 vs. log 2.0 DNA copies/ml, p < 0.05). Males (OR = 1.8, 95% CI: 1.0, 3.2) were more likely to be HBsAg positive than female. HCV seroprevalence was 0.9% in HIV-positive individuals. Conclusion. The prevalence of HBsAg carriage in HIV- infected Gambians is similar to that obtained in the general population. However co-infected individuals with reduced CD4 levels, indicative of AIDS had higher prevalence of HBeAg retention and elevated HBV DNA levels compared to non-AIDS patients with higher CD4 count.

Original languageEnglish
Article number230
JournalVirology Journal
Publication statusPublished - 2010

Bibliographical note

Copyright 2010 Elsevier B.V., All rights reserved.


Dive into the research topics of 'Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians'. Together they form a unique fingerprint.

Cite this